Page last updated: 2024-11-06

3-methoxysalicylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-Methoxysalicylic acid, also known as 3-hydroxy-4-methoxybenzoic acid, is a naturally occurring phenolic compound found in various plants. It exhibits diverse biological activities, including antioxidant, anti-inflammatory, and antimicrobial properties. The compound has been studied for its potential therapeutic applications, particularly in the treatment of inflammatory conditions and skin disorders. Its synthesis can be achieved through various methods, including the methylation of salicylic acid or the oxidation of 3-methoxyphenol. The compound's importance lies in its versatility and potential benefits for human health. Its antioxidant properties contribute to its protective effects against oxidative stress, while its anti-inflammatory properties may alleviate inflammation associated with various diseases.'

2-hydroxy-3-methoxybenzoic acid: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID70140
CHEMBL ID450441
CHEBI ID68496
SCHEMBL ID5458
MeSH IDM0515126

Synonyms (52)

Synonym
3-hydroxy-m-anisic acid
brn 2209642
nsc 408167
einecs 212-888-9
nsc 134533
nsc134533
nsc-134533
2-hydroxy-3-methoxybenzoic acid
o-vanillic acid
877-22-5
3-methoxysalicylic acid ,
acide orthovanillique
m-anisic acid, 2-hydroxy-
benzoic acid, 2-hydroxy-3-methoxy-
wln: qvr bq co1
2-hydroxy-3-methoxy-benzoic acid
nsc-408167
nsc408167
inchi=1/c8h8o4/c1-12-6-4-2-3-5(7(6)9)8(10)11/h2-4,9h,1h3,(h,10,11
2-hydroxy-3-methoxybenzoic acid, 97%
AC-11840
chebi:68496 ,
CHEMBL450441
m1153 ,
guaiacol-3-carboxylic acid
AKOS000120843
A842351
3-10-00-01363 (beilstein handbook reference)
unii-3j31y0e2im
3j31y0e2im ,
FT-0615968
STL372636
AM20060745
3-methoxy-2-hydroxybenzoic acid
salicylic acid, 3-methoxy-
3-methoxy-salicylic acid
BBL027382
2-hydroxy-3-methoxy benzoic acid
SCHEMBL5458
mfcd00002445
SY014328
5-chloro-3-phenyl-1-benzofuran-2-carboxylicacid
W-104007
3-methoxysalicylicacid
DTXSID20236566
CS-W017817
'3-methoxy-2-hydroxobenzoic acid
Q27136978
AS-10831
F52710
EN300-21507
Z104500498
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
methoxysalicylic acidA monohydroxybenzoic acid that is salicylic acid which carries a methoxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID338339Antiplatelet activity against rat platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation at 1 mg/ml pretreated 2 mins before ADP challenge
AID1090826Antifeedant activity against Hylobius abietis (pine weevil ) in compound pre-treated Scots pine twig at 50 mM measured after 24 hr by two-choice laboratory bioassay2007Journal of agricultural and food chemistry, Nov-14, Volume: 55, Issue:23
Quantitative structure-activity relationships of pine weevil antifeedants, a multivariate approach.
AID338333Antiplatelet activity against rat platelet rich plasma assessed as inhibition of arachidonic acid-induced platelet aggregation at 0.5 mg/ml pretreated 2 mins before arachidonic acid challenge
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.11

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.11 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.42 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.11)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]